Fortis Healthcare Ltd vs Suraksha Diagnostic Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Fortis Healthcare Ltd is ₹ 769.8 as of 30 Oct 15:30 . The P/E Ratio of Fortis Healthcare Ltd changed from 39.5 on March 2022 to 57.6 on March 2026 . This represents a CAGR of 7.84% over 5 yearsThe P/E Ratio of Suraksha Diagnostic Ltd changed from 42.2 on March 2025 to 36.9 on March 2026 . This represents a CAGR of -6.49% over 2 years The Market Cap of Fortis Healthcare Ltd changed from ₹ 15023 crore on March 2021 to ₹ 59988 crore on March 2026 . This represents a CAGR of 25.96% over 6 yearsThe Market Cap of Suraksha Diagnostic Ltd changed from ₹ 1342 crore on March 2025 to ₹ 1187 crore on March 2026 . This represents a CAGR of -5.95% over 2 years The revenue of Fortis Healthcare Ltd for the Jun '26 is ₹ 2573 crore as compare to the Mar '26 revenue of ₹ 2375 crore. This represent the growth of 8.34% The revenue of Suraksha Diagnostic Ltd for the Jun '26 is ₹ 88.73 crore as compare to the Mar '26 revenue of ₹ 82.2 crore. This represent the growth of 7.94% The ebitda of Fortis Healthcare Ltd for the Jun '26 is ₹ 565.5 crore as compare to the Mar '26 ebitda of ₹ 530.45 crore. This represent the growth of 6.61% The ebitda of Suraksha Diagnostic Ltd for the Jun '26 is ₹ 31.53 crore as compare to the Mar '26 ebitda of ₹ 25.15 crore. This represent the growth of 25.37% The net profit of Fortis Healthcare Ltd changed from ₹ 173.98 crore to ₹ 272.8 crore over 9 quarters. This represents a CAGR of 22.13% The net profit of Suraksha Diagnostic Ltd changed from ₹ 7.67 crore to ₹ 12.85 crore over 9 quarters. This represents a CAGR of 25.78% The Dividend Payout of Fortis Healthcare Ltd changed from 78.45 % on March 2023 to 32.78 % on March 2026 . This represents a CAGR of -19.60% over 4 yearsThe Dividend Payout of Suraksha Diagnostic Ltd changed from 0.76 % on March 2026 to 0.76 % on March 2026 . This represents a CAGR of 0.00% over 1 years .

About Fortis Healthcare Ltd

Fortis Healthcare Limited (FHL) is one of the largest healthcare services providers in India with 27 hospitals, ~4,750+ operational beds and 400+ diagnostics centres as of 31 March, 2025.
The Company offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services to patients in areas such as Cardiac Care, Orthopedics, Neurosciences, Oncology, renal care, Gastroenterology and Mother and Child care..
They are delivering quality healthcare services to patients in modern facilities using advanced technology. SRL Limited, a subsidiary of FHL is primarily involved in providing diagnostics services and is amongst the leading diagnostics chains in India with a significant market share in the organized diagnostics segment.

About Suraksha Diagnostic Ltd

Suraksha Diagnostic Limited was incorporated as Suraksha Diagnostic Private Limited' as a private limited company dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata.
Subsequently, Company was converted into a public limited company and the name of Company was changed to Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre. The Company is mainly engaged in running diagnostic centres for carrying out various pathological and radiological testing and medical consultation services in in East India.
In addition to integrated pathology and radiology testing services, it also offer omnichannel medical consultation services via online and offline modes to customers through 43 of its diagnostic centres which house 120 polyclinic chambers hosting 750+ doctors.

FAQs for the comparison of Fortis Healthcare Ltd and Suraksha Diagnostic Ltd

Which company has a larger market capitalization, Fortis Healthcare Ltd or Suraksha Diagnostic Ltd?

Market cap of Fortis Healthcare Ltd is 58,116 Cr while Market cap of Suraksha Diagnostic Ltd is 1,653 Cr

What are the key factors driving the stock performance of Fortis Healthcare Ltd and Suraksha Diagnostic Ltd?

The stock performance of Fortis Healthcare Ltd and Suraksha Diagnostic Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fortis Healthcare Ltd and Suraksha Diagnostic Ltd?

As of October 31, 2026, the Fortis Healthcare Ltd stock price is INR ₹769.8. On the other hand, Suraksha Diagnostic Ltd stock price is INR ₹317.4.

How do dividend payouts of Fortis Healthcare Ltd and Suraksha Diagnostic Ltd compare?

To compare the dividend payouts of Fortis Healthcare Ltd and Suraksha Diagnostic Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.